Advertisement
Canada markets open in 9 hours 25 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7303
    +0.0005 (+0.07%)
     

  • CRUDE OIL

    82.87
    +0.06 (+0.07%)
     

  • Bitcoin CAD

    88,043.76
    -3,218.84 (-3.53%)
     

  • CMC Crypto 200

    1,391.09
    -33.01 (-2.32%)
     

  • GOLD FUTURES

    2,325.00
    -13.40 (-0.57%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,460.25
    -204.25 (-1.16%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    37,699.23
    -760.85 (-1.98%)
     

  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of CXO, BSTC, MYOK, and CBMG Mergers

Rigrodsky & Long, P.A.
·2 min read

WILMINGTON, Del., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

Concho Resources Inc. (NYSE: CXO) regarding possible breaches of fiduciary duties and other violations of law related to Concho Resources’ agreement to be acquired by ConocoPhillips. Under the terms of the agreement Concho Resources’ shareholders will receive 1.46 shares of ConocoPhillips’ common stock per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-concho-resources-inc.

BioSpecifics Technologies Corp. (NASDAQ GM: BSTC) regarding possible breaches of fiduciary duties and other violations of law related to BioSpecifics Technologies’ agreement to be acquired by Endo International plc. Under the terms of the agreement, BioSpecifics Technologies’ shareholders will receive $88.50 in cash per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-biospecifics-technologies-corp.

MyoKardia, Inc. (NASDAQ GS: MYOK) regarding possible breaches of fiduciary duties and other violations of law related to MyoKardia’s agreement to be acquired by Bristol-Myers Squibb Company. Under the terms of the agreement, MyoKardia’s shareholders will receive $225.00 in cash per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-myokardia-inc.

ADVERTISEMENT

Cellular Biomedicine Group, Inc. (NASDAQ GS: CBMG) regarding possible breaches of fiduciary duties and other violations of law related to Cellular Biomedicine’s agreement to be acquired by a consortium headed by Bizuo (Tony) Liu. Under the terms of the agreement Cellular Biomedicine’s shareholders will receive $19.75 per share in cash. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-cellular-biomedicine-group-inc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
https://rl-legal.com